Clinical Trial

Liquid Biopsy in Glioblastoma Treated With Chemoradiation and an Oxygen Therapeutic

Name: Liquid Biopsy in Glioblastoma Treated With Chemoradiation and an Oxygen Therapeutic — clinical trial record (NCT07417774)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: RESTORE LB

Enrolling by Invitation

View on ClinicalTrials.gov →

Summary

The goal of this sub-study of the RESTORE trial is to identify biomarkers associated with tumor hypoxia, identify biomarkers that differentiate pseudoprogression from true progression, and correlate biomarkers with clinical outcomes.

Trial Details

NCT Number	NCT07417774
Lead Sponsor	NuvOx LLC Collaborators: National Cancer Institute (NCI)
Conditions	Glioblastoma (GBM)
Enrollment	40 participants
Start Date	2025-12-08
Primary Completion	2027-12 (estimated)
Study Completion	2030-12 (estimated)
Updated on ClinicalTrials.gov	2026-02-18